Pure Global

LIAISON Multi Control Tumor Marker - India CDSCO Medical Device Registration

LIAISON Multi Control Tumor Marker is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000089_629e4ac8401b51aeb445eddd52621483_7a0dba432c6f4a41768a826bc11b2a6c. This device is marketed under the brand name LIAISON® EASY System Liquid. The license holder is Diasorin Healthcare India Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
LIAISON Multi Control Tumor Marker
UID: IMP/IVD/2019/000089_629e4ac8401b51aeb445eddd52621483_7a0dba432c6f4a41768a826bc11b2a6c

Brand Name

LIAISON® EASY System Liquid

Device Class

Class B

Approving Authority

CDSCO

Product Information

The LIAISON® Multi-Control Tumour Markers (LIAISON® EASY System Liquid) are to be used in LIAISON® chemiluminescent immunoassays (LIAISON® EASY System Liquid) as a means of checking reliability of assay runs. The performance characteristics of LIAISON® Multi-Control Tumour Markers have not been established for any other assays or instrument platforms different from LIAISON® and LIAISON® XL

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing